HMGB1 as a potential new marker of disease activity in patients with multiple sclerosis

被引：0
|
作者：
Maria Bucova
Beata Majernikova
Vladimira Durmanova
Daniela Cudrakova
Karin Gmitterova
Iveta Lisa
Eleonora Klimova
Kristina Kluckova
Milan Buc
机构：
[1] Comenius University,Institute of Immunology, Faculty of Medicine
[2] Comenius University and University Hospital,1st. Department of Neurology, Faculty of Medicine
[3] Comenius University,2nd Department of Neurology, Faculty of Medicine
[4] Faculty Hospital of JA Raiman,Centre for Therapy and Diagnosis of Multiple Sclerosis
来源：
Neurological Sciences | 2020年 / 41卷
关键词：
HMGB1; Immunity; Inflammation; Multiple sclerosis; EDSS; MSSS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：599 / 604
页数：5
相关论文
共 50 条
  • [1] HMGB1 as a potential new marker of disease activity in patients with multiple sclerosis
    Bucova, Maria
    Majernikova, Beata
    Durmanova, Vladimira
    Cudrakova, Daniela
    Gmitterova, Karin
    Lisa, Iveta
    Klimova, Eleonora
    Kluckova, Kristina
    Buc, Milan
    NEUROLOGICAL SCIENCES, 2020, 41 (03) : 599 - 604
  • [2] NUCLEOSOMES, HMGB1 AND RAGE AS NEW PROGNOSTIC MARKER AFTER MULTIPLE TRAUMA
    Roessner, Juliane
    Wolf, K.
    Hoecherl, E. F.
    Durner, J.
    Hallbach, J.
    Hofmann, W.
    Nagel, D.
    Holdenrieder, S.
    TUMOR BIOLOGY, 2010, 31 : S76 - S76
  • [3] HMGB1: A new marker for estimation of the postmortem interval
    Kikuchi, Kiyoshi
    Kawahara, Ko-Ichi
    Biswas, Kamal Krishna
    Ito, Takashi
    Tancharoen, Salunya
    Shiomi, Naoto
    Koda, Yoshiro
    Matsuda, Fumiyo
    Morimoto, Yoko
    Oyama, Yoko
    Takenouchi, Kazunori
    Miura, Naoki
    Arimura, Noboru
    Nawa, Yuko
    Arimura, Shinichiro
    Jie, Meng Xiao
    Shrestha, Binita
    Iwata, Masahiro
    Mera, Kentaro
    Sameshima, Hisayo
    Ohno, Yoshiko
    Maenosono, Ryuichi
    Tajima, Yutaka
    Uchikado, Hisaaki
    Kuramoto, Terukazu
    Nakayama, Kenji
    Shigemori, Minoru
    Yoshida, Yoshihiro
    Hashiguchi, Teruto
    Maruyama, Ikuro
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2010, 1 (01) : 109 - 111
  • [4] Role of high mobility group box protein 1 (HMGB1) in patients with multiple sclerosis
    Malhotra, S.
    Fissolo, N. M.
    Castillo, J.
    Vidal-Jordana, A.
    Montalban, X.
    Comabella, M.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 49 - 49
  • [5] HMGB1 - a new prognostic marker in the development of diabetic cardiomyopathy?
    Andrassy, M.
    Volz, C.
    Kaya, Z.
    Bierhaus, A.
    Katus, H.
    DIABETOLOGIA, 2008, 51 : S51 - S52
  • [6] HMGB1 is related to disease activity in children with celiac disease
    Yagci, Murat
    Aydemir, Yusuf
    Baris, Zeren
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (07)
  • [7] HMGB1, a potential new target for mesothelioma therapy
    Jube, Sandro
    Rivera, Zeyana
    Gaudino, Giovanni
    Pass, Harvey I.
    Bianchi, Marco E.
    Carbone, Michele
    Yang, Haining
    CANCER RESEARCH, 2011, 71
  • [8] High mobility group box 1 (HMGB1) protein in Multiple Sclerosis (MS): Mechanisms and therapeutic potential
    Paudel, Yam Nath
    Angelopoulou, Efthalia
    Bhuvan, K. C.
    Piperi, Christina
    Othman, Iekhsan
    LIFE SCIENCES, 2019, 238
  • [9] HMGB1: a potential new target for tendinopathy treatment
    Lu, Panpan
    Li, Yingjuan
    Dai, Guangchun
    Zhang, Yuanwei
    Shi, Liu
    Zhang, Ming
    Wang, Hao
    Rui, Yunfeng
    CONNECTIVE TISSUE RESEARCH, 2023, 64 (04) : 362 - 375
  • [10] The Relationship Between Disease Activity and Levels of HMGB1 in Patients with Rheumatoid Arthritis
    Pisetsky, David S.
    Spencer, Diane
    Wisniewski, Stephen R.
    Lyons, Jason
    Saul, Melissa
    McGeachy, Mandy J.
    Hwang, Yong Gil
    Eng, Heather
    Moreland, Larry W.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S172 - S172
12345